The study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease.
Small proteins that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study.
The 2023 VCNG Continuation of Service Award was presented to Jennifer Ross, an Executive MBA Metro NY candidate in the Samuel Curtis Johnson Graduate School of Management at the Cornell SC Johnson College of Business.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Cornell Tech researchers have developed a mechanism for preserving anonymity in encrypted messaging – which conceals message content but might not cloak the sender’s identity – while simultaneously blocking unwanted or abusive messages.
“Fashioning the Boundaries of Free Speech,” an exhibit that’s part of Cornell’s Freedom of Expression theme year, will be on display in the Human Ecology Building and the Herbert F. Johnson Museum of Art from Sept. 28 to Jan. 15, 2024.
Cornell has established the Department of Design Tech, a Radical Collaboration partnership between five colleges that seeks to enhance design and technology education and research across the university.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.